Helius Medical Tech (OTC:HSDTW) Stock, Quote.Headers.trade-ideas

Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.

Helius Medical Technologies Inc Warrants (02/02/2026)

Helius Medical Technologies Inc

Wednesday, Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) promoted Rose Castanares, executive vice president of the Arizona unit, as president.
Castanares, who joined the Taiwanese contract chipmaker in 1998, will take over Brian Harrison on October 1, who will retire on December 31, the Taipei Times <a target="_blank" href="https://www.taipeitimes.com/News/biz/archives/2024/09/19/2003823993" rel="noreferrer noopener">cites</a> in a company statement.
TSM stock is trading higher on Thursday as the U.S. Federal Reserve <a target="_blank" href="https://in.benzinga.com/markets/equities/24/09/40932103/it-stocks-on-the-rise-after-u-s-fed-cuts-interest-rate" rel="noreferrer noopener">slashed its benchmark</a> interest rate by 50 basis points, setting the interest rate at 4.75%-5% to&nbsp;spur demand for discretionary spending from U.S. companies.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40904754/amazons-leaner-structure-and-ai-chip-partnership-with-intel-could-boost-growth-bofa" rel="noreferrer noopener">Amazon&#8217;s Leaner Structure and AI Chip Partnership with Intel Could Boost Growth: BofA Analyst</a>
The <a target="_blank" href="https://www.benzinga.com/government/24/04/38249052/samsung-secures-6-4b-from-us-for-texas-chip-factory-after-nvidia-supplier-tsmcs-breakthrough" rel="noreferrer noopener">contract chipmaker recently raised</a> its U.S. investment by more than 60% to $65 billion, as the country granted a $6.6 billion federal grant and provided $5 billion in loans.
TSMC is a key artificial intelligence chip supplier for Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) and is building two advanced fabs in Arizona, leveraging the 4nm, 3nm, and 2nm processes.
It is also eyeing a third fab in Arizona, leveraging the 2nm process. Earlier this year, the company won approval to infuse $7.5 billion in the Arizona unit, reflecting its conviction in the <a target="_blank" href="https://www.benzinga.com/news/24/09/40928754/what-has-taiwan-semiconductor-stock-done-since-nvidia-earnings" rel="noreferrer noopener">artificial intelligence frenzy</a>, which it also voiced at the Semicon Taiwan industry forum in Taipei.
Recent reports also indicated Taiwan Semiconductor bagging at least two smartphone chip deals concerning Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google, and Apple. Samsung Electronics (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SSNLF#OTC">SSNLF</a>) Samsung Foundry recently lost out on the Pixel 10 and Pixel 11 chip deals to Taiwan Semiconductor&#8217;s chipmaking technology.
A separate report indicated that Taiwan Semiconductor has started making Apple&#8217;s iPhone chip A16 SoC at the Arizona unit, leveraging its 5nm N4 technology.
Taiwan Semiconductor stock has risen 90% in the last 12 months. Investors can gain exposure to semiconductor stocks through&nbsp;the VanEck Semiconductor ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMH#NASDAQ">SMH</a>) and&nbsp;the&nbsp;iShares Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOXX#NASDAQ">SOXX</a>).
Price Action:&nbsp;TSM stock is up 3.88% at $173.78 at the last check on Thursday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/m-a/24/09/40926078/nvidia-considers-165m-octoai-acquisition-aims-to-strengthen-ai-and-cloud-dominance" target="_blank" rel="noreferrer noopener">Nvidia Considers $165M OctoAI Acquisition, Aims to Strengthen AI and Cloud Dominance</a></li>
</ul>
Photo by Sundry Photography on Shutterstock

Government

News

Regulations

Movers

Tech

Media

AAPL

GOOG

GOOGL

NVDA

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

SSNLF

What's Going On With Taiwan Semiconductor Stock On Thursday?

RBC Capital analyst Gregory Renza reiterates Viridian Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRDN#NASDAQ">VRDN</a>) with a Outperform and maintains $44 price target.

Price Target

Reiteration

Analyst Ratings

VRDN

RBC Capital Reiterates Outperform on Viridian Therapeutics, Maintains $44 Price Target

Trading Ideas

Haoxi Health Technology Shares Halted On Circuit Breaker, Stock Now Down -77.3%

RZLV

Rezolve AI Shares Resume Trade

RBC Capital analyst Luca Issi reiterates Korro Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRRO#NASDAQ">KRRO</a>) with a Outperform and maintains $95 price target.

KRRO

RBC Capital Reiterates Outperform on Korro Bio, Maintains $95 Price Target

WIIM

BNZI

Banzai International shares are trading lower after the company announced a 1-for-50 reverse stock split.

AAR Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIR#NYSE">AIR</a>) will release earnings results for its first quarter fiscal year 2025, after the <a href="https://www.benzinga.com/quote/AIR/earnings">closing bell on Monday, Sept. 13.</a>
Analysts expect the Wood Dale, Illinois-based company to report quarterly earnings at 84 cents per share, up from 78 cents per share in the year-ago period. AAR is projected to post quarterly revenue of $646.06 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Sept. 16, AAR and Defense Logistics Agency Land and Maritime signed a supply chain alliance to enhance joint support for U.S. warfighter.
AAR shares gained 1.4% to close at $68.89 on Wednesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/TCOM/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5dfa5c7f3513fb0001efbfda/ken-herbert">RBC Capital analyst Ken Herbert </a>maintained an Outperform rating and raised the price target from $80 to $85 on July 19. This analyst has an accuracy rate of 68%.</li>
<li>Stifel analyst Bert Subin maintained a Buy rating and slashed the price target from $86 to $85 on July 19. This analyst has an accuracy rate of 62%.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/58a5e02a43eaaa00018d93a0/josh-sullivan">Benchmark analyst Josh Sullivan</a> maintained a Buy rating and raised the price target from $65 to $83 on April 15. This analyst has an accuracy rate of 84%.</li>
<li>William Blair analyst Louie DiPalma initiated coverage on the stock with an Outperform rating on Jan. 29. This analyst has an accuracy rate of 72%.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5935519e85b07a0001c0bc51/michael-ciarmoli">Truist Securities analyst Michael Ciarmoli</a> maintained a Buy rating and increased the price target from $68 to $81 on Dec. 22, 2023. This analyst has an accuracy rate of 77%.</li>
</ul>
Considering buying AIR stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="509" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19024722/image-144-1024x509.png" alt="" class="wp-image-555444" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19024722/image-144-1024x509.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19024722/image-144-300x149.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19024722/image-144-768x382.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19024722/image-144.png 1342w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: &lt;a href=&#8221;https://www.benzinga.com/news/24/04/38268727/top-4-tech-stocks-you-may-want-to-dump-in-april&#8221;&gt;&lt;em&gt; Top 4 Tech Stocks You May Want To Dump In April &lt;/em&gt;&lt;/a&gt;

Top Wall Street Forecasters Revamp AAR Price Expectations Ahead Of Q1 Earnings

BABA

Alibaba shares are trading higher after the company announced the launch of more than 100 new open-source AI models and introduced a text-to-video generation tool.

AerCap shares are trading higher after the company announced a $500 million share repurchase program.

GSIW

Garden Stage Limited Shares Resume Trade

Investors with a lot of money to spend have taken a bullish stance on Goldman Sachs Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with GS, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 10 uncommon options trades for Goldman Sachs Gr.
This isn't normal.
The overall sentiment of these big-money traders is split between 30% bullish and 30%, bearish.
Out of all of the special options we uncovered, 3 are puts, for a total amount of $128,230, and 7 are calls, for a total amount of $438,154.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $230.0 to $510.0 for Goldman Sachs Gr over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Goldman Sachs Gr's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Goldman Sachs Gr's significant trades, within a strike price range of $230.0 to $510.0, over the past month.
<h3>Goldman Sachs Gr 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726754687_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>GS</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$42.5</td>
<td>$40.85</td>
<td>$41.67</td>
<td>$490.00</td>
<td>$129.1K</td>
<td>207</td>
<td style="text-align: right;">32</td>
</tr>
<tr>
<td>GS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$20.0</td>
<td>$19.4</td>
<td>$20.0</td>
<td>$490.00</td>
<td>$100.0K</td>
<td>843</td>
<td style="text-align: right;">50</td>
</tr>
<tr>
<td>GS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$27.05</td>
<td>$26.6</td>
<td>$26.6</td>
<td>$480.00</td>
<td>$79.8K</td>
<td>732</td>
<td style="text-align: right;">37</td>
</tr>
<tr>
<td>GS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$5.3</td>
<td>$4.9</td>
<td>$4.9</td>
<td>$500.00</td>
<td>$48.0K</td>
<td>1.4K</td>
<td style="text-align: right;">8</td>
</tr>
<tr>
<td>GS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>09/20/24</td>
<td>$5.2</td>
<td>$4.25</td>
<td>$4.85</td>
<td>$497.50</td>
<td>$48.0K</td>
<td>87</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>

<h3>About Goldman Sachs Gr</h3>
Goldman Sachs is a leading global investment banking and asset management firm. Approximately 20% of its revenue comes from investment banking, 45% from trading, 20% from asset management and 15% from wealth management and retail financial services. Around 60% of the company's net revenue is generated in the Americas, 15% in Asia, and 25% in Europe, the Middle East, and Africa.
Following our analysis of the options activities associated with Goldman Sachs Gr, we pivot to a closer look at the company's own performance.
<h3>Goldman Sachs Gr's Current Market Status</h3>
<ul>
<li>With a volume of 273,638, the price of GS is up 2.09% at $494.71. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 26 days.</li>
</ul>
<h3>Professional Analyst Ratings for Goldman Sachs Gr</h3>
In the last month, 1 experts released ratings on this stock with an average target price of $472.0.
<ul>
<li>An analyst from JP Morgan persists with their Overweight rating on Goldman Sachs Gr, maintaining a target price of $472. </li>
</ul>
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Goldman Sachs Gr options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

Markets

Goldman Sachs Gr's Options Frenzy: What You Need to Know

Investors with a lot of money to spend have taken a bearish stance on Upstart Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPST#NASDAQ">UPST</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with UPST, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 8 uncommon options trades for Upstart Hldgs.
This isn't normal.
The overall sentiment of these big-money traders is split between 25% bullish and 62%, bearish.
Out of all of the special options we uncovered, 3 are puts, for a total amount of $83,564, and 5 are calls, for a total amount of $173,045.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $30.0 and $45.0 for Upstart Hldgs, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Upstart Hldgs's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Upstart Hldgs's whale activity within a strike price range from $30.0 to $45.0 in the last 30 days. 
<h3>Upstart Hldgs 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726754682_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>UPST</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/20/24</td>
<td>$4.3</td>
<td>$4.0</td>
<td>$4.0</td>
<td>$35.00</td>
<td>$40.0K</td>
<td>5.3K</td>
<td style="text-align: right;">77</td>
</tr>
<tr>
<td>UPST</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$11.9</td>
<td>$11.9</td>
<td>$11.9</td>
<td>$40.00</td>
<td>$35.7K</td>
<td>2.9K</td>
<td style="text-align: right;">63</td>
</tr>
<tr>
<td>UPST</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$11.8</td>
<td>$11.55</td>
<td>$11.6</td>
<td>$30.00</td>
<td>$34.8K</td>
<td>1.1K</td>
<td style="text-align: right;">31</td>
</tr>
<tr>
<td>UPST</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$1.37</td>
<td>$1.19</td>
<td>$1.37</td>
<td>$39.00</td>
<td>$34.2K</td>
<td>948</td>
<td style="text-align: right;">326</td>
</tr>
<tr>
<td>UPST</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/27/24</td>
<td>$1.18</td>
<td>$1.15</td>
<td>$1.16</td>
<td>$37.50</td>
<td>$28.8K</td>
<td>170</td>
<td style="text-align: right;">344</td>
</tr>
</tbody>
</table>

<h3>About Upstart Hldgs</h3>
Upstart Holdings Inc provides credit services. The company provides a proprietary, cloud-based, artificial intelligence lending platform. The platform aggregates consumer demand for loans and connects it to the network of Upstart AI-enabled bank partners. Upstart's platform includes personal loans, automotive retail and refinance loans, home equity lines of credit and small dollar loans.
Following our analysis of the options activities associated with Upstart Hldgs, we pivot to a closer look at the company's own performance.
<h3>Where Is Upstart Hldgs Standing Right Now?</h3>
<ul>
<li>With a volume of 1,646,831, the price of UPST is up 2.1% at $39.11. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 47 days.</li>
</ul>
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Upstart Hldgs options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

UPST

What the Options Market Tells Us About Upstart Hldgs

Financial giants have made a conspicuous bullish move on Novo Nordisk. Our analysis of options history for Novo Nordisk (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) revealed 11 unusual trades.
Delving into the details, we found 45% of traders were bullish, while 36% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $62,093, and 9 were calls, valued at $571,553.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $70.0 to $140.0 for Novo Nordisk over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Novo Nordisk's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Novo Nordisk's whale activity within a strike price range from $70.0 to $140.0 in the last 30 days. 
<h3>Novo Nordisk Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726754677_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NVO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$2.87</td>
<td>$2.85</td>
<td>$2.86</td>
<td>$140.00</td>
<td>$160.0K</td>
<td>1.1K</td>
<td style="text-align: right;">495</td>
</tr>
<tr>
<td>NVO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$25.0</td>
<td>$24.15</td>
<td>$25.0</td>
<td>$130.00</td>
<td>$125.0K</td>
<td>701</td>
<td style="text-align: right;">50</td>
</tr>
<tr>
<td>NVO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$14.3</td>
<td>$14.1</td>
<td>$14.1</td>
<td>$135.00</td>
<td>$63.4K</td>
<td>726</td>
<td style="text-align: right;">51</td>
</tr>
<tr>
<td>NVO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>10/18/24</td>
<td>$2.92</td>
<td>$2.86</td>
<td>$2.89</td>
<td>$140.00</td>
<td>$59.8K</td>
<td>1.1K</td>
<td style="text-align: right;">796</td>
</tr>
<tr>
<td>NVO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/11/24</td>
<td>$4.35</td>
<td>$4.25</td>
<td>$4.3</td>
<td>$135.00</td>
<td>$36.5K</td>
<td>108</td>
<td style="text-align: right;">85</td>
</tr>
</tbody>
</table>

<h3>About Novo Nordisk</h3>
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Having examined the options trading patterns of Novo Nordisk, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Where Is Novo Nordisk Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 292,034, the NVO's price is up by 1.92%, now at $134.59. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 42 days.</li>
</ul>
<h3>What The Experts Say On Novo Nordisk</h3>
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $160.0.
<ul>
<li>Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $160.</li>
<li>Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $160.</li>
</ul>
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Novo Nordisk, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Spotlight on Novo Nordisk: Analyzing the Surge in Options Activity

Corteva (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTVA#NYSE">CTVA</a>) has outperformed the market over the past 5 years by 1.44% on an annualized basis producing an average annual return of 15.42%. Currently, Corteva has a market capitalization of $40.04 billion. 
Buying $1000 In CTVA: If an investor had bought $1000 of CTVA stock 5 years ago, it would be worth $2,002.94 today based on a price of $57.84 for CTVA at the time of writing.
<h3>Corteva's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726754644_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CTVA

$1000 Invested In Corteva 5 Years Ago Would Be Worth This Much Today

Plug Power Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>) shares are trading higher today. The hydrogen solutions&nbsp;provider launched <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/g40935208/plug-power-launches-an-equipment-lease-financing-platform-plug-is-targeting-150-million-from-a-com" rel="noreferrer noopener">an equipment lease financing platform</a>.
The company aims to raise over $150 million in the near to mid-term through a combination of debt leverage and customer financing solutions.
The platform is designed to unlock capital from Plug&#8217;s equipment assets and offer financing options to drive sales growth.
In its initial step, Plug finalized three sale and leaseback deals totaling around $44 million with GTL Leasing, a portfolio company of Antin Infrastructure Partners.
&#8220;It provides for immediate capital with a path to additional capital over the near term, supports our growth in the green hydrogen sector, and aligns with Plug&#8217;s financial and operational objectives,&#8221; stated Plug CFO, Paul Middleton.
These agreements cover hydrogen transport and storage equipment, including trailers and cryogenic storage tanks. The transactions allow Plug to retain access to essential hydrogen equipment while enhancing its financial flexibility.
The capital raised will be reinvested into core operations, supporting the company&#8217;s long-term growth and expansion plans.
The platform is designed to improve Plug&#8217;s operational efficiency and resource management while providing partners like GTL with an attractive investment opportunity to grow their leased asset portfolios.
For GTL and other participants, this partnership offers long-term revenue potential, portfolio diversification, and deeper involvement in the green hydrogen economy, positioning them for sustained growth and expansion.
Nathalie Kosciusko-Morizet and Stephan Feilhauer, Senior Partner and Partner respectively at Antin Infrastructure Partners stated, &#8220;These transactions not only provide GTL with a robust portfolio of storage tanks and trailers—both cryogenic and gaseous—but also support some of the largest distribution centers in the U.S.&#8221;
On Wednesday, Plug Power secured a 25-megawatt (MW) order for its proton exchange membrane (PEM) electrolyzer systems from a major oil company <a target="_blank" href="https://www.benzinga.com/markets/equities/24/09/40934580/why-is-plug-power-stock-surging-premarket-on-thursday" rel="noreferrer noopener">joint&nbsp;venture, Castellón Green Hydrogen S.L</a>.
Investors can gain access to the stock via&nbsp;Global X Hydrogen ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYDR#NASDAQ">HYDR</a>) and&nbsp;ETF Series Solutions Defiance Next Gen H2 ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HDRO#NYSE">HDRO</a>).
Also Read: <a target="_blank" href="https://www.benzinga.com/24/08/40288778/plug-power-misses-q2-revenues-analysts-focus-on-electrolyzer-deployments-the-bar-was-set-low" rel="noreferrer noopener">Plug Power Misses&nbsp;Q2&nbsp;Revenues, Analysts Focus On Electrolyzer Deployments: ‘The Bar Was Set Low'</a>
Price Action: PLUG shares are up 5.95% at $2.225 at the last check Thursday.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/40938804" target="_blank" rel="noreferrer noopener">GameStop CEO Ryan Cohen Penalized Nearly $1M Over Wells Fargo Share Acquisition</a></li>
</ul>

Equities

Large Cap

Contracts

ETF Series Solutions Defiance Next Gen H2 ETF

HDRO

HYDR

PLUG

Plug Power Fuels Sales Boom With $150M+ Equipment Leasing Strategy - What's The Benefit?

U.S. Consumer Product Safety Commission Says Polaris Recalls Sportsman All-Terrain Vehicles Due To Fire Hazard; Polaris Recalls About 10,300 ATVs And 3,158 Fuel Pump Kits And Fuel Tank Assemblies Due To Fire Hazard; Polaris Recalls Ranger XD 1500 Recreational Off-Road Vehicles With Winches Due To Fire Hazard

FDMT

4D Molecular Therapeutics shares are trading lower. Leerink Partners lowered its price target on the stock from $40 to $36.

Wells Fargo analyst James Feldman maintains Sun Communities (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUI#NYSE">SUI</a>) with a Equal-Weight and raises the price target from $123 to $154.

Wells Fargo Maintains Equal-Weight on Sun Communities, Raises Price Target to $154

Rocket Lab USA, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) shares are trading <a href="https://www.benzinga.com/movers">higher on Thursday.</a>
In a social media <a target="_blank" href="https://x.com/RocketLab/status/1836542888530088310" rel="noreferrer noopener">post </a>in X, formerly Twitter, the company stated that, &#8220;Today&#8217;s launch attempt for @KineisIoT experienced a safe on-pad abort at T-0.&#8221;
The company added that, since the mission required an instantaneous launch, they would be standing down from any further attempts that day.
Rocket Lab had planned to launch five nanosatellites for Kineis, a startup supported by the French space agency, <a href="https://www.bloomberg.com/news/articles/2024-09-18/rocket-lab-aborts-satellite-launch-after-countdown-reaches-zero?sref=TBDibEcD" target="_blank" rel="noreferrer noopener">reported</a> Bloomberg. The attempt that was aborted was made in New Zealand.
&#8220;The team is assessing opportunities for the next launch attempt and we&#8217;ll share more information here shortly,&#8221; Rocket Lab said.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/24/09/40934972/wall-street-primed-for-relief-rally-as-traders-eye-jobless-claims-fedex-earnings-after-feds-50-basi" rel="noreferrer noopener">Wall Street Primed For Relief Rally As Traders Eye Jobless Claims, FedEx Earnings After Fed&#8217;s 50 Basis-Point Cut: Strategist Says These Stocks Will Gain Edge In First 6 Months Of Rate Cut</a>
The company&#8217;s CEO, Peter Beck, <a href="https://x.com/Peter_J_Beck/status/1836553721708237055" target="_blank" rel="noreferrer noopener">mentioned </a>on X that the abort was caused by ground support equipment failing to meet its target within the allocated time, emphasizing the importance of ensuring that everything on the ground is as well-functioning as everything in the sky.
&#8220;We like everything on the ground to be just as happy as everything in the sky,&#8221; the CEO said.
According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>, RKLB stock has gained over 52% in the past year. Investors can gain exposure to the stock via Procure Space ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UFO#NASDAQ">UFO</a>).
The company recently announced that Frank Klein is its new chief operations officer, effective Sept. 16. According to Beck, the company plans to improve the Electron launch schedule, implement Neutron, and strengthen its satellite and space systems divisions<a href="https://www.benzinga.com/markets/equities/24/09/40816135/rocket-lab-usa-hires-rivian-veteran-frank-klein-as-new-coo-whats-going-on" target="_blank" rel="noreferrer noopener">.</a>
Price Action: RKLB shares are trading higher by 3.4% to $7.21 at last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/09/40937873/walmart-steps-up-holiday-game-inflation-free-thanksgiving-meal-returns" target="_blank" rel="noreferrer noopener">Walmart Steps Up Holiday Game, Inflation-Free Thanksgiving Meal Returns</a></li>
</ul>
Photo: Shutterstock

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Helius Medical Tech

Helius Medical Tech (HSDTW) Forecast

Helius Medical Tech (OTC:HSDTW) Stock, Quote.Headers.trade-ideas